FDA
Battling the Bulge
Battling the Bulge
Bob Grant | Nov 1, 2015
Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.
Following FDA OK, 23andMe to Expand Health Prediction
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015
The personal genomics firm is ramping up its suite of disease-related genetic tests.
FDA Warns Liquid Biopsy Maker
FDA Warns Liquid Biopsy Maker
Bob Grant | Sep 25, 2015
The agency fires off a letter to Pathway Genomics, telling the company that its new cancer detection test could harm the public and is not validated by science.
Duke Cardiologist Tapped to Lead FDA
Duke Cardiologist Tapped to Lead FDA
Bob Grant | Sep 17, 2015
The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.
TS Picks: September 8, 2015
TS Picks: September 8, 2015
Jef Akst | Sep 8, 2015
Pharma edition
The Sounds of Silence
The Sounds of Silence
Jenny Rood | Sep 1, 2015
Science-based tinnitus therapeutics are finally coming into their own.
Valeant Scoops Sprout for $1 Billion
Valeant Scoops Sprout for $1 Billion
Tracy Vence | Aug 24, 2015
The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”
“Female Viagra” Approved
“Female Viagra” Approved
Jef Akst | Aug 19, 2015
The US Food and Drug Administration OKs the first drug for female sexual dysfunction.
Report: Impact of Biomedical Research Slipping
Report: Impact of Biomedical Research Slipping
Jef Akst | Aug 18, 2015
Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.
Doctor Who Blocked Thalidomide Dies
Doctor Who Blocked Thalidomide Dies
Kerry Grens | Aug 11, 2015
Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.